UNLV Innovation Day 2024


May. 13, 2024, 9am to 4pm

Campus Location

Office/Remote Location

Student Union Ballroom
UNLV Innovation Day logo


Join us to kick off the exciting inaugural UNLV Innovation Day, the first of its kind to engage students, faculty, and future entrepreneurs to innovate, create, and collaborate. 

Don’t miss the opportunity to meet the start-up scientists, innovators, and entrepreneurs; hear from leaders of the National Institute on Aging and UNLV President Whitfield; learn about emerging trends and expand their network; and watch the pitch competition with the final prizes of $19,000. 

Get ready to be inspired, empowered, and informed. 

This is a free event; lunch will be provided. 

Please register at UNLV Innovation Day.


This is a free community event.

Admission Information

This event is open to UNLV students, faculty, staff, and the community. Please register at UNLV Innovation Day.

Contact Information


External Sponsor

UNLV Innovation Day is presented by:
INNOVATOR Program – The UNLV Alzheimer's Disease and Related Dementias Innovation Incubator (INNOVATOR) Program is funded by the National Institute on Aging with the goal of engaging students (pre-doc, doctoral, post-doctoral) and junior faculty in innovation and entrepreneurship in the life sciences.
Ascend2.0 Program – The ASCEND (Accelerating Solutions for Commercialization and Entrepreneurial Development) 2.0 Program serves the seven Mountain West IDeA States. To increase entrepreneurship and commercialization of basic medical science in the Mountain West states, the ASCEND solution provides: awareness on how technologies are brought to market, access to sufficient technology development, resources for early-stage technology development, entrepreneurial expertise and culture, and exposure to commercialization education, training, and funding programs
TNeuroPharma – At TNeuroPharma, we believe in the power of innovative science. We believe that there’s always another way to look at a problem to find a solution. We believe that in the complex area of neurodegenerative diseases, an earlier definitive diagnosis could be the root for understanding -- and the key to moving forward. Most importantly, we believe that effective treatments for Alzheimer’s disease and other neurodegenerative disorders are within our reach. And our goal is to assist and support today’s pharmaceutical companies reach the milestone the world has been waiting for when it comes to drug development for Alzheimer’s and other neurodegenerative diseases.